Doç. Dr. GÖZDE MÜTEVELİZADE

Makaleler 12

1. Radiation-induced Xerostomia: Evaluation with ¹⁸F-FDG PET/CT

MÜTEVELİZADE G., Bozdemir B. C., Aydin N., Suner A. F., KARAKOYUN ÇELİK Ö., PARLAK Y., et al.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.34, sa.3, ss.213-220, 2025 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

2. Predicting clinical outcomes using 18F-FDG PET/CT-based radiomic features and machine learning algorithms in patients with esophageal cancer

MÜTEVELİZADE G., Aydin N., Duran Can O., TEKE O., Suner A. F., ERDUĞAN M., et al.

Nuclear Medicine Communications , cilt.46, sa.9, ss.835-847, 2025 (SCI-Expanded, Scopus)

3. The role of [68Ga]Ga-DOTA-TATE PET/CT in breast cancer imaging: a prospective study compared with [18F]FDG PET/CT

Sezgin C., PARLAK Y., MÜTEVELİZADE G., COŞKUN T., Sayit E., GÜMÜŞER F. G.

Clinical and Translational Imaging , cilt.13, sa.4, ss.407-420, 2025 (SCI-Expanded, Scopus)

4. An Innovative Approach with [68Ga]Ga-PSMA PET/CT: The Relationship Between PRIMARY Scores and Clinical and Histopathological Findings

MÜTEVELİZADE G., BOZDEMİR B. Ç., Aydin N., Sayit E.

Diagnostics , cilt.15, sa.14, 2025 (SCI-Expanded, Scopus)

5. Predicting thyroid cancer ablation success: Pre-ablative 99mTc-Pertechnetate and post-ablative 131I scan comparison Prédiction du succès de l'ablation dans le cancer de la thyroïde : une comparaison de la scintigraphie pré-ablative à la 99mTc-pertechnétate et de la scintigraphie post-ablative au 131I

MÜTEVELİZADE G., PARLAK Y., BOZDEMİR B. Ç., Sezgin C., Gumuser G., Sayit E.

Medecine Nucleaire , cilt.49, sa.3, ss.179-186, 2025 (SCI-Expanded, Scopus)

6. A Comprehensive Analysis of Volumetric68Ga-PSMA PET/CT Parameters, Clinical and Histopathologic Features: Evaluation of the Predictive Role Volümetrik68Ga-PSMA PET/BT Parametreleri, Klinik ve Histopatolojik Özelliklerin Kapsamlı Bir Analizi: Prediktif Rolün Değerlendirilmesi

MÜTEVELİZADE G., PARLAK Y., Arıkbası C. S., Gümüşer G., Sayit E.

Molecular Imaging and Radionuclide Therapy , cilt.33, sa.2, ss.68-76, 2024 (ESCI, Scopus, TRDizin)

7. Splenosis imaging with 99mTc nano-colloid as a different mimicker in a lymphoma patient on 18F- FDG PET/CT Scintigraphie aux nanocolloïdes-33mTc pour différencier une splénose d'un ganglion lymphatique fixant le 18F-FDG

Sezgin C., PARLAK Y., MÜTEVELİZADE G., Gumuser G., Sayit E.

Medecine Nucleaire , cilt.48, sa.3, ss.165-167, 2024 (SCI-Expanded, Scopus)

8. Primary pleural synovial sarcoma with diffuse pleural involvement: A case report Sarcome synovial pleural primitif avec atteinte pleurale diffuse : un rapport de cas

MÜTEVELİZADE G., Sayit E.

Medecine Nucleaire , cilt.47, sa.4, ss.218-220, 2023 (SCI-Expanded, Scopus)

9. Inguinoscrotal Bladder Hernia Mimicking Testicle Tumor

Sezgin C., Duzgun F., MÜTEVELİZADE G., Gumuser G., Sayit E.

Clinical Medicine Insights: Case Reports , cilt.16, 2023 (ESCI, Scopus)

10. The effect of sodium iodide symporter protein on ablation success in patients with differentiated thyroid cancer

MÜTEVELİZADE G., Kocer N. E., Reyhan M.

Annals of Nuclear Medicine , cilt.36, sa.12, ss.1050-1058, 2022 (SCI-Expanded, Scopus)

11. Contribution of Open Mouth Technique in18F-FDG PET/CT Imaging in Patients with Malignant Lip Neoplasm Dudak Malign Neoplazmı Tanılı Hastaların18F-FDG PET/BT Görüntülemesinde Ağız Açık Pozisyonlamanın Katkısı

MÜTEVELİZADE G., Sezgin C., PARLAK Y., Gümüşer G., Sayit E.

Molecular Imaging and Radionuclide Therapy , cilt.31, sa.3, ss.172-178, 2022 (Scopus, TRDizin)

12. Unexpected Metastatic Localizations of Prostate Cancer Determined by68Ga PSMA PET/CT: Series of Four Cases 68 Ga PSMA PET/BT’de Saptanan Prostat Kanserinin Nadir Metastaz Lokalizasyonları: Dört Olgu

MÜTEVELİZADE G., Sezgin C., Gümüşer G., Sayit E.

Molecular Imaging and Radionuclide Therapy , cilt.31, sa.3, ss.223-226, 2022 (Scopus, TRDizin)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 49

1. Innovative Approaches in Prostate Cancer Management: The Efficacy of Ga-68 PSMA PET/CT in Detecting Bone Metastases

BOZDEMİR B. Ç., MÜTEVELİZADE G., AYDIN N., GÜMÜŞER F. G., BİLGİN B. E.

EANM 2024, Hamburg, Almanya, 19 Ekim 2024, (Özet Bildiri)

2. The Relationship Between Biometric Data And Lymphoscintigraphic Findings In Patients With Lower Extremity Lymphedema

MÜTEVELİZADE G., AYMANDİR G., KILIÇ R., AYDIN N., BOZDEMİR B. Ç., PARLAK Y., et al.

EANM 2024, Hamburg, Almanya, 19 Ekim 2024, (Özet Bildiri)

3. Predicting Treatment Response in Esophageal Cancer Patients Using 18F FDG PET/CT Texturel Features Parameters

MÜTEVELİZADE G., DURAN GERÇEKCİOĞLU Ö., AYDIN N., ERDUĞAN M., SUNER A. F., BİLGİN B. E.

EANM 2024, Hamburg, Almanya, 19 Ekim 2024, (Özet Bildiri)

4. An Innovative Approach with Ga-68 PSMA PET/CT: The PRIMARY Scoring System

AYDIN N., MÜTEVELİZADE G., BOZDEMİR B. Ç., BİLGİN B. E.

EANM 2024, Hamburg, Almanya, 19 Ekim 2024, (Özet Bildiri)

5. A Case Report: Primary Renal Lymphoma Presenting with a Pathological Femur Fracture

AYDIN N., MÜTEVELİZADE G., BOZDEMİR B. Ç., BİLGİN B. E.

EANM 2024, Hamburg, Almanya, 19 Ekim 2024, (Özet Bildiri)

6. Risk Assessment of Xerostomia Using F18 FDG PET/CT Metabolic Parameters After Radiotherapy in Head And Neck Cancers

BOZDEMİR B. Ç., MÜTEVELİZADE G., AYDIN N., SUNER A. F., KARAKOYUN ÇELİK Ö., KOCABAŞOĞLU E., et al.

EANM 2024, Hamburg, Almanya, 19 Ekim 2024, (Özet Bildiri)

7. Risk Assessment of Xerostomia Using F¹⁸ FDG PET/CT Metabolic Parameters After Radiotherapy in Head And Neck Cancers

BOZDEMİR B. Ç., MÜTEVELİZADE G., Aydin N., Suner A. F., ÇELİK Ö., Kocabasoglu E., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 19 - 23 Ekim 2024, cilt.51, (Özet Bildiri)